No Association of filaggrin copy number variation and atopic dermatitis risk in White and Black Americans.
No Association of filaggrin copy number variation and atopic dermatitis risk in White and Black Americans.
复制标题
美国白人和黑人中丝聚蛋白拷贝数变异与特应性皮炎风险之间没有关联。
DOI:
10.1111/exd.14449
复制
发表时间:
2022
影响因子:
3.6
通讯作者:
Common,JohnE
中科院分区:
文献类型:
--
作者:
Fulton,RachelL;Margolis,DavidJ;Sockler,PatrickG;Mitra,Nandita;Wong,XuanFeiColinCornelius;Common,JohnE
Atopic dermatitis (AD) is a chronic, inflammatory skin condition with a multifactorial pathophysiology. The filaggrin gene (FLG) has particularly been implicated given loss of function (LoF) mutations in this gene lead to skin barrier dysfunction and such mutations can increase a patient's likelihood of developing AD.FLGhas intragenic copy number variation (CNV), which impacts the total amount of filaggrin produced. Previous research reported a dose‐dependent effect such that as amount of FLG increases, risk of AD decreases. To gain a better understanding, we evaluatedFLGCNV in a large case‐control study of Whites and Blacks with and without AD. The goal of our study was to determine whetherFLGCNV has a dose‐dependent effect on the risk of developing AD and to determine whetherFLGCNV varies by race. The frequencies and odds ratios comparing a given CNV by race or race within those with AD did not significantly vary. It had been thought thatFLGCNV might vary by race and represent an important association with AD in Black AD subjects. However, our work suggests that while there are racial differences with respect to CNV, these differences do not appear to explain AD risk.